Gene · 1024
Papers2,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Formation of nuclear condensates by the Mediator complex subunit Med15 in mammalian cells. | BMC Biol | 2021 | 34789250 | PubTator, text mining | PubMed |
| Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase. | Cancers (Basel) | 2021 | 34771669 | PubTator, text mining | PubMed |
| Drug Repositioning Based on the Reversal of Gene Expression Signatures Identifies TOP2A as a Therapeutic Target for Rectal Cancer. | Cancers (Basel) | 2021 | 34771654 | PubTator, text mining | PubMed |
| Synthesis and Antiproliferative Activity of 2,4,6,7-Tetrasubstituted-2H-pyrazolo[4,3-c]pyridines. | Molecules | 2021 | 34771163 | PubTator, text mining | PubMed |
| Efficient Hit-to-Lead Searching of Kinase Inhibitor Chemical Space via Computational Fragment Merging. | J Chem Inf Model | 2021 | 34762402 | PubTator, text mining | PubMed |
| Targeting transcriptional regulators for treatment of anaplastic thyroid cancer. | J Cancer Metastasis Treat | 2021 | 34761120 | PubTator, text mining | PubMed |
| Discovery of 3-amino-4-{(3S)-3-[(2-ethoxyethoxy)methyl]piperidin-1-yl}thieno[2,3-b]pyridine-2-carboxamide (DS96432529): A potent and orally active bone anabolic agent. | Bioorg Med Chem Lett | 2021 | 34742889 | PubTator, text mining | PubMed |
| Two interacting transcriptional coactivators cooperatively control plant immune responses. | Sci Adv | 2021 | 34739308 | PubTator, text mining | PubMed |
| Transcription recycling assays identify PAF1 as a driver for RNA Pol II recycling. | Nat Commun | 2021 | 34732721 | PubTator, text mining | PubMed |
| Author Correction: Long non-coding RNA HEIH modulates CDK8 expression by inhibiting miR-193a-5p to accelerate nasopharyngeal carcinoma progression. | Eur Rev Med Pharmacol Sci | 2021 | 34730192 | PubTator, text mining | PubMed |
| Network-based protein-protein interaction prediction method maps perturbations of cancer interactome. | PLoS Genet | 2021 | 34727106 | PubTator, text mining | PubMed |
| Integrated loss- and gain-of-function screens define a core network governing human embryonic stem cell behavior. | Genes Dev | 2021 | 34711655 | PubTator, text mining | PubMed |
| Structural and functional analysis of somatic coding and UTR indels in breast and lung cancer genomes. | Sci Rep | 2021 | 34707120 | PubTator, text mining | PubMed |
| circ_0038718 promotes colon cancer cell malignant progression via the miR-195-5p/Axin2 signaling axis and also effect Wnt/β-catenin signal pathway. | BMC Genomics | 2021 | 34706645 | PubTator, text mining | PubMed |
| HSV-1 ICP22 Is a Selective Viral Repressor of Cellular RNA Polymerase II-Mediated Transcription Elongation. | Vaccines (Basel) | 2021 | 34696162 | PubTator, text mining | PubMed |
| Long non-coding RNA HEIH: a novel tumor activator in multiple cancers. | Cancer Cell Int | 2021 | 34689775 | PubTator, text mining | PubMed |
| Triple-negative breast cancer cells rely on kinase-independent functions of CDK8 to evade NK-cell-mediated tumor surveillance. | Cell Death Dis | 2021 | 34689158 | PubTator, text mining | PubMed |
| Cdk8 Kinase Module: A Mediator of Life and Death Decisions in Times of Stress. | Microorganisms | 2021 | 34683473 | PubTator, text mining | PubMed |
| Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives. | Cancers (Basel) | 2021 | 34680255 | PubTator, text mining | PubMed |
| RPARP-AS1/miR125a-5p Axis Promotes Cell Proliferation, Migration and Invasion in Colon Cancer. | Onco Targets Ther | 2021 | 34675548 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1024/papers?page=32